Reports
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States
Americas
Future Market Insights, Inc.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
MEA
Future Market Insights
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom
Asia Pacific
Future Market Insights
IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India
According to Future Market Insights research, during the projected period, the global cardiovascular diagnostics market is expected to grow at a CAGR of 5.1%. The market value is projected to increase from US$ 5.9 Billion in 2023 to US$ 9.7 Billion by 2033. The cardiovascular diagnostics market was valued at US$ 5.6 Billion at the end of 2022 and is anticipated to exhibit Y-o-Y growth of 4.3% in 2023.
Market Outlook:
Data Points | Market Insights |
---|---|
Market Value 2022 | US$ 5.6 Billion |
Market Value 2023 | US$ 5.9 Billion |
Market Value 2033 | US$ 9.7 Billion |
CAGR 2023 to 2033 | 5.1% |
Market Share of Top 5 Countries | 54.6% |
Key Market Players | Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co. KG, Schiller, Koninklijke Philips N.V., GE Healthcare and Wayra, Siemens Healthcare, Lepu Medical, Midmark Corp, Roche Ltd, Randox Laboratories Ltd., Robonik India, Diasorin, and Elabscience Biotechnology Inc. |
An electrocardiogram (ECG) is a basic test that may be performed to assess the rhythm and electrical activity of the heart. Equipment like ECG, holter monitoring devices, and other imaging solutions aid in the diagnosis of certain cardiac disorders, such as irregular heart rhythms and coronary heart disease (heart attack). ECG monitors the electrical signal from the heart in order to diagnose various heart diseases. Electrodes are put on the chest to record the electrical signals produced by the heart, which cause the heart to beat. On an associated computer monitor or printer, the signals are displayed as waves. Resting Electrocardiography (ECG) is a non-invasive examination that can identify arrhythmias, signs of coronary heart disease, left ventricular hypertrophy, and bundle branch blockages.
The continent's high prevalence of avoidable heart failure should call attention to prevention as a significant area of effort. Investing in high-quality epidemiological research, including therapeutic interventions, prioritising early diagnosis, and optimising therapies based on evidence-based medicine should also be prioritised. A complete physical examination is required for cardiovascular disease (CVD) diagnosis.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The market value for global cardiovascular diagnostics contributes around 3.3% with the US$ 170.0 Billion global diagnostics market in 2022.
The sale of cardiovascular diagnostics expanded at a CAGR of 4.2% from 2017 to 2022, due to the increasing demand for cardiovascular diagnostics. The growth in CVDs in the global population is another reason driving up demand for cardiovascular diagnostics. The continent is now undergoing an epidemiological change, with non-communicable diseases expected to overtake communicable illnesses within the next decade.
CVD associated factors have contributed to an upsurge in high blood pressure, cardiomyopathies, and atherosclerosis illnesses, resulting in an increase in the incidence of strokes and cardiac failure. Thus, owing to such factors, the global cardiovascular diagnostics market is expected to grow at a CAGR of 5.1% during the forecast period.
Manufacturers have immense opportunity to innovate and improve patient care within the cardiovascular diagnostics business. Manufacturers have been improving the accuracy and efficiency of cardiovascular diagnostics by developing and advancing imaging technologies such as magnetic resonance imaging (MRI), computed tomography (CT), and ultrasound. Image quality, resolution, and real-time visualisation improvements can assist in the identification and diagnosis of cardiovascular problems.
The demand for quick and easy diagnostic testing at the point of care is also growing. Manufacturers are in process to create and commercialise portable, user-friendly diagnostic gadgets that deliver rapid and accurate findings for cardiovascular disorders. Point-of-care testing allows for early identification and quick action, resulting in better patient outcomes.
Biomarkers are critical in the diagnosis and monitoring of cardiovascular disorders. Manufacturers are concentrating on the discovery and validation of new biomarkers, as well as the development of novel molecular diagnostic procedures that provide precise and personalised patient evaluations. These tests can help with risk assessment, illness monitoring, and therapy selection.
There have been some significant attempts globally, to increase health-care facilities. For example, the health policy for 2009 to 2025 calls for €20 billion in expenditures in structural upgrading of current hospitals and the building of new medical facilities. In addition to constructing new facilities, governments across the globe, are investing in technology and innovation to enhance healthcare. Telemedicine and e-health solutions, for example, are becoming increasingly widespread in the region, allowing healthcare practitioners to conduct remote consultations and more quickly access patient data.
The utilization of data analytics and artificial intelligence (AI) algorithms are another sector, which help assist in the interpretation and analysis of cardiovascular diagnostic data. Manufacturers are developing software solutions that leverage AI to provide predictive analytics, risk assessment models, and decision support tools, ultimately improving diagnostic accuracy and clinical decision-making.
The demand for cardiovascular diagnostics is restrained by several factors. Many countries, particularly in underdeveloped regions, lack basic healthcare facilities. Access to the availability of cardiovascular diagnostics is hampered by a shortage of well-equipped hospitals, diagnostic facilities, and specialised cardiovascular care centres. This reduces the demand for diagnostic services. The scarcity of competent healthcare workers, such as cardiologists, technicians, and nurses, limits demand for cardiovascular diagnostics significantly. The scarcity of qualified professionals has an impact on the prompt and correct detection of cardiovascular problems, resulting in treatment delays and lower demand for diagnostic testing.
Financial problems, such as restricted private sector investment in healthcare and low healthcare budgets in some countries, might stymie the expansion of the cardiovascular diagnostics market. Inadequate funding for modern diagnostic equipment and drugs limits the availability and accessibility of cardiovascular diagnostic services. Inadequate legislation and policies, particularly in the Middle East and North Africa (MENA), can stymie the growth and distribution of healthcare professionals. In the absence of strong rules, there may be a lack of standardised training programmes, insufficient incentives for healthcare personnel, and limited access to high-quality cardiovascular diagnostics.
In 2022, the USA held a dominant share of in the North American market and contributed around US$ 1.8 Billion in 2022.
The United States is a large market for cardiovascular diagnostics due to several factors. To begin, the prevalence of cardiovascular diseases such as heart disease and hypertension in the United States necessitates the development of diagnostic equipment to diagnose and monitor these ailments. The country has a sophisticated healthcare infrastructure that includes cutting-edge medical facilities as well as a large network of healthcare providers.
Presence of world-class research universities and pharmaceutical businesses also helps to ensure that cutting-edge diagnostic equipment is available. Furthermore, due to the high level of healthcare expenditure and insurance coverage in the United States, the general public has increased access to cardiovascular diagnostic services.
China holds nearly 5.9% market share in the global Cardiovascular Diagnostics market in 2022, and is projected to display growth at a CAGR of 8.2% during the forecasted period.
Due to a variety of circumstances, China is a highly profitable market for cardiovascular diagnostics. For starters, the country has a vast population, and the prevalence of cardiovascular disorders is rising, resulting in a high need for diagnostic services. Second, the government has made significant investments in healthcare infrastructure, such as cardiovascular care centres, which has increased access to diagnostic tests.
China's increasing middle class has more disposable cash and a greater knowledge of health risks, resulting in an increase in demand for preventative healthcare, particularly cardiovascular diagnostics. Furthermore, technological improvements and alliances with multinational corporations have made modern diagnostic instruments and techniques more widely available in the Chinese market.
Germany accounted for a market value share of around 6.4% in 2022, in the global cardiovascular diagnostics market.
Several variables influence the German market for cardiovascular diagnostics. First, Germany has a well-developed healthcare infrastructure, with cutting-edge medical facilities and a high level of healthcare spending. Second, because of the country's strong emphasis on preventative healthcare and early diagnosis, there is a considerable need for cardiovascular diagnostic tests.
Third, Germany's population is ageing, which increases the prevalence of cardiovascular disorders and the need for effective diagnostic methods. Fourth, the presence of world-class healthcare corporations and research institutions in Germany promotes innovation and technology advances in cardiovascular diagnostics. Finally, government activities and policies that promote healthcare access and quality contribute to market growth.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
In 2022, Electrocardiogram (ECG) Systems held 43.4% of market share of cardiovascular diagnostic market. The Electrocardiogram (ECG) product segment is assisting the global cardiovascular diagnostics market in its growth. ECG is a non-invasive diagnostic method used to detect problems in cardiovascular function by measuring the electrical activity of the heart.
With a 43.4% market share, ECG systems has shown to be an important technique for diagnosing and monitoring cardiovascular problems. Its non-invasiveness, ease of use, and capacity to deliver vital insights into cardiovascular health make it a preferred choice among healthcare professionals, contributing to the worldwide cardiovascular diagnostics market's growth and advancement.
Hospitals held a market share of around 30.5% in 2022 globally. Hospitals, specialty clinics, diagnostic imaging centres, ambulatory surgical centres, and cardiac catheterization labs, among others, provide the services. Hospitals address significant patients compared to specialty clinics, diagnostic imaging centres, ambulatory surgical centres. Hospitals are highly preferred place for diagnosis and treatment of cardiovascular disease, due to availability of skilled staff, latest diagnostic equipment and treatment options all under one roof.
The leading competitors in the cardiovascular diagnostics market are employing various methods to increase sales and income. These companies are developing technical breakthroughs for new product releases in order to fulfil customer demand and expand. The industry is highly fragmented, with several small and medium-sized players vying for market share.
Among the strategies employed by market participants in the Cardiovascular Diagnostics industry are:
Similarly, recent developments related to the company’s manufacturing the cardiovascular diagnostics have been tracked by the team at Future Market Insights, which are available in the full report.
Attribute | Details |
---|---|
Forecast Period | 2023 to 2033 |
Historical Data Available for | 2017 to 2022 |
Market Analysis | US$ Million for Value, Units for Volume |
Key Regions Covered | North America, Latin America, East Asia, South Asia & Pacific, Western Europe, Eastern Europe, Central Asia, Middle East and Africa (MEA) |
Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, Germany, Italy, France, UK, Spain, BENELUX, Russia, India, Thailand, China, Indonesia, Malaysia, Japan, South korea, Australia, New Zealand, GCC countries, North Africa and South Africa. |
Key Market Segments Covered | Product, End User, and Region |
Key Companies Profiled |
|
Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
Pricing | Available upon Request |
The cardiovascular diagnostics market is worth US$ 5.9 billion in 2023.
The cardiovascular diagnostics market is estimated to record a 5.1% CAGR through 2033.
The top 5 countries occupy 55.6% of the cardiovascular diagnostics market shares.
The electrocardiogram (ECG) segment is the leading product segment in the market.
China is expected to rise at a prominent CAGR of 8.2% in the market.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply-Side Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Innovation / Development Trends 4. Value-Added Insights 4.1. Disease Epidemiology, By Key Indication 4.2. Installed Equipment Scenario 4.3. Number of Surgery Procedures, By Key Countries 4.4. Payer Mix Analysis 4.5. Value Chain Analysis 4.6. Key Regulations 4.7. PESTLE Analysis 4.8. Porter’s Analysis 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Growth Outlook 5.1.2. Global Healthcare Spending Outlook 5.1.3. Global Market Overview 5.2. Forecast Factors - Relevance & Impact 5.2.1. Increasing Demand for Healthcare Devices 5.2.2. Increasing Strategic Activities Among Players to Increase Product Reach 5.2.3. Growing Advancements Leading to an Increase in the Number of Indications 5.2.4. Increasing Number of Diagnostic Procedures 5.2.5. Growing Acceptance of Surgery Procedures 5.2.6. Shift from Invasive to Non-invasive Laser Diagnosis 5.2.7. Increasing Development of Technological Advanced Products 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. Global Market Demand (in Volume (Units) Analysis 2017 to 2022 and Forecast, 2023 to 2033 6.1. Historical Market Volume (Units) Analysis, 2017 to 2022 6.2. Current and Future Market Volume (Units) Projections, 2023 to 2033 6.2.1. Y-o-Y Growth Trend Analysis 7. Global Market- Pricing Analysis 7.1. Regional Pricing Analysis by Product 7.2. Global Average Pricing Analysis Benchmark 7.3. Pricing Assumptions 8. Global Market Demand (in Value or Size in US$ Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033 8.1. Historical Market Value (US$ Million) and Volume (Units) Analysis 2017 to 2022 8.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033 8.2.1. Y-o-Y Growth Trend Analysis 8.2.2. Absolute $ Opportunity Analysis 9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Product, 2017 to 2022 9.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast, By Product, 2023 to 2033 9.3.1. Electrocardiogram (ECG) Systems 9.3.1.1. Resting ECG Systems 9.3.1.2. Cardiopulmonary Stress Testing Systems 9.3.2. Holter Monitoring Devices 9.3.3. Event Monitoring Devices 9.3.3.1. Implantable Loop Recorder (ILR) 9.3.3.2. Others 9.3.4. Point of Care Testing 9.3.4.1. Analyzers 9.3.4.2. Lipoprotein Test Kits 9.3.4.3. Angiotensin Test Kits 9.3.4.4. Fibrinogen Test Kits 9.3.4.5. Serum Uric Acid Test Kits 9.3.4.6. High-Sensitivity CRP (hs-CRP) Kit 9.4. Market Attractiveness Analysis by Product 10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User 10.1. Introduction 10.2. Historical Market Size (US$ Million) Analysis by End User, 2017 to 2022 10.3. Current and Future Market Size (US$ Million) Analysis and Forecast by End User, 2023 to 2033 10.3.1. Hospitals 10.3.2. Ambulatory Surgical Centers 10.3.3. Specialty Clinics 10.3.4. Cardiac Catheterization Labs 10.3.5. Diagnostic Imaging Centers 10.4. Market Attractiveness Analysis by End User 11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region 11.1. Introduction 11.2. Historical Market Value (US$ Million) and Volume (Units) Analysis by Region, 2017 to 2022 11.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast, By Region, 2023 to 2033 11.3.1. North America 11.3.2. Latin America 11.3.3. Europe 11.3.4. South Asia 11.3.5. East Asia 11.3.6. Oceania 11.3.7. Middle East & Africa 11.4. Market Attractiveness Analysis by Region 12. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 12.1. Introduction 12.2. Historical Market Value (US$ Million) and Volume (Units) Analysis, By Market Taxonomy 2017 to 2022 12.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2023 to 2033 12.3.1. By Country 12.3.1.1. USA 12.3.1.2. Canada 12.3.2. By Product 12.3.3. By End User 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. By Product 12.4.3. By End User 12.5. Market Trends 12.6. Key Market Participants - Intensity Mapping 12.7. Drivers and Restraints - Impact Analysis 12.8. Country Level Analysis & Forecast 12.8.1. USA Market 12.8.1.1. Introduction 12.8.1.2. Market Analysis and Forecast by Market Taxonomy 12.8.1.2.1. By Product 12.8.1.2.2. By End User 12.8.2. Canada Market 12.8.2.1. Introduction 12.8.2.2. Market Analysis and Forecast by Market Taxonomy 12.8.2.2.1. By Product 12.8.2.2.2. By End User 13. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 13.1. Introduction 13.2. Historical Market Value (US$ Million) and Volume (Units) Analysis, By Market Taxonomy 2017 to 2022 13.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2023 to 2033 13.3.1. By Country 13.3.1.1. Brazil 13.3.1.2. Mexico 13.3.1.3. Argentina 13.3.1.4. Rest of Latin America 13.3.2. By Product 13.3.3. By End User 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Product 13.4.3. By End User 13.5. Market Trends 13.6. Key Market Participants - Intensity Mapping 13.7. Drivers and Restraints - Impact Analysis 13.8. Country Level Analysis & Forecast 13.8.1. Brazil Market 13.8.1.1. Introduction 13.8.1.2. Market Analysis and Forecast by Market Taxonomy 13.8.1.2.1. By Product 13.8.1.2.2. By End User 13.8.2. Mexico Market 13.8.2.1. Introduction 13.8.2.2. Market Analysis and Forecast by Market Taxonomy 13.8.2.2.1. By Product 13.8.2.2.2. By End User 13.8.3. Argentina Market 13.8.3.1. Introduction 13.8.3.2. Market Analysis and Forecast by Market Taxonomy 13.8.3.2.1. By Product 13.8.3.2.2. By End User 14. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033 14.1. Introduction 14.2. Historical Market Value (US$ Million) and Volume (Units) Analysis, By Market Taxonomy 2017 to 2022 14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2023 to 2033 14.3.1. By Country 14.3.1.1. Germany 14.3.1.2. Italy 14.3.1.3. France 14.3.1.4. UK 14.3.1.5. Spain 14.3.1.6. BENELUX 14.3.1.7. Russia 14.3.1.8. Rest of Europe 14.3.2. By Product 14.3.3. By Application 14.3.4. By End User 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Product 14.4.3. By End User 14.5. Market Trends 14.6. Key Market Participants - Intensity Mapping 14.7. Drivers and Restraints - Impact Analysis 14.8. Country Level Analysis & Forecast 14.8.1. Germany Market 14.8.1.1. Introduction 14.8.1.2. Market Analysis and Forecast by Market Taxonomy 14.8.1.2.1. By Product 14.8.1.2.2. By End User 14.8.2. Italy Market 14.8.2.1. Introduction 14.8.2.2. Market Analysis and Forecast by Market Taxonomy 14.8.2.2.1. By Product 14.8.2.2.2. By End User 14.8.3. France Market 14.8.3.1. Introduction 14.8.3.2. Market Analysis and Forecast by Market Taxonomy 14.8.3.2.1. By Product 14.8.3.2.2. By End User 14.8.4. UK Market 14.8.4.1. Introduction 14.8.4.2. Market Analysis and Forecast by Market Taxonomy 14.8.4.2.1. By Product 14.8.4.2.2. By End User 14.8.5. Spain Market 14.8.5.1. Introduction 14.8.5.2. Market Analysis and Forecast by Market Taxonomy 14.8.5.2.1. By Product 14.8.5.2.2. By End User 14.8.6. BENELUX Market 14.8.6.1. Introduction 14.8.6.2. Market Analysis and Forecast by Market Taxonomy 14.8.6.2.1. By Product 14.8.6.2.2. By End User 14.8.7. Russia Market 14.8.7.1. Introduction 14.8.7.2. Market Analysis and Forecast by Market Taxonomy 14.8.7.2.1. By Product 14.8.7.2.2. By End User 15. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 15.1. Introduction 15.2. Historical Market Value (US$ Million) and Volume (Units) Analysis, By Market Taxonomy 2017 to 2022 15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2023 to 2033 15.3.1. By Country 15.3.1.1. China 15.3.1.2. Japan 15.3.1.3. South Korea 15.3.2. By Product 15.3.3. By End User 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Product 15.4.3. By End User 15.5. Market Trends 15.6. Key Market Participants - Intensity Mapping 15.7. Drivers and Restraints - Impact Analysis 15.8. Country Level Analysis & Forecast 15.8.1. China Market 15.8.1.1. Introduction 15.8.1.2. Market Analysis and Forecast by Market Taxonomy 15.8.1.2.1. By Product 15.8.1.2.2. By End User 15.8.2. Japan Market 15.8.2.1. Introduction 15.8.2.2. Market Analysis and Forecast by Market Taxonomy 15.8.2.2.1. By Product 15.8.2.2.2. By End User 15.8.3. South Korea Market 15.8.3.1. Introduction 15.8.3.2. Market Analysis and Forecast by Market Taxonomy 15.8.3.2.1. By Product 15.8.3.2.2. By End User 16. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 16.1. Introduction 16.2. Historical Market Value (US$ Million) and Volume (Units) Analysis, By Market Taxonomy 2017 to 2022 16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2023 to 2033 16.3.1. By Country 16.3.1.1. India 16.3.1.2. Indonesia 16.3.1.3. Malaysia 16.3.1.4. Thailand 16.3.1.5. Rest of South Asia 16.3.2. By Product 16.3.3. By End User 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Product 16.4.3. By End User 16.5. Market Trends 16.6. Key Market Participants - Intensity Mapping 16.7. Drivers and Restraints - Impact Analysis 16.8. Country Level Analysis & Forecast 16.8.1. India Market 16.8.1.1. Introduction 16.8.1.2. Market Analysis and Forecast by Market Taxonomy 16.8.1.2.1. By Product 16.8.1.2.2. By End User 16.8.2. Indonesia Market 16.8.2.1. Introduction 16.8.2.2. Market Analysis and Forecast by Market Taxonomy 16.8.2.2.1. By Product 16.8.2.2.2. By End User 16.8.3. Malaysia Product Market 16.8.3.1. Introduction 16.8.3.2. Market Analysis and Forecast by Market Taxonomy 16.8.3.2.1. By Product 16.8.3.2.2. By End User 16.8.4. Thailand Market 16.8.4.1. Introduction 16.8.4.2. Market Analysis and Forecast by Market Taxonomy 16.8.4.2.1. By Product 16.8.4.2.2. By End User 17. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033 17.1. Introduction 17.2. Historical Market Value (US$ Million) and Volume (Units) Analysis, By Market Taxonomy 2017 to 2022 17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2023 to 2033 17.3.1. By Country 17.3.1.1. Australia 17.3.1.2. New Zealand 17.3.2. By Product 17.3.3. By End User 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Product 17.4.3. By End User 17.5. Market Trends 17.6. Key Market Participants - Intensity Mapping 17.7. Drivers and Restraints - Impact Analysis 17.8. Country Level Analysis & Forecast 17.8.1. Australia Product Market 17.8.1.1. Introduction 17.8.1.2. Market Analysis and Forecast by Market Taxonomy 17.8.1.2.1. By Product 17.8.1.2.2. By End User 17.8.2. New Zealand Product Market 17.8.2.1. Introduction 17.8.2.2. Market Analysis and Forecast by Market Taxonomy 17.8.2.2.1. By Product 17.8.2.2.2. By End User 18. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033 18.1. Introduction 18.2. Historical Market Value (US$ Million) and Volume (Units) Analysis, By Market Taxonomy 2017 to 2022 18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2023 to 2033 18.3.1. By Country 18.3.1.1. GCC Countries 18.3.1.2. Türkiye 18.3.1.3. South Africa 18.3.1.4. Northern Africa 18.3.1.5. Rest of Middle East and Africa 18.3.2. By Product 18.3.3. By End User 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Product 18.4.3. By End User 18.5. Market Trends 18.6. Key Market Participants - Intensity Mapping 18.7. Drivers and Restraints - Impact Analysis 18.8. Country Level Analysis & Forecast 18.8.1. GCC Countries Market 18.8.1.1. Introduction 18.8.1.2. Market Analysis and Forecast by Market Taxonomy 18.8.1.2.1. By Product 18.8.1.2.2. By End User 18.8.2. Türkiye Market 18.8.2.1. Introduction 18.8.2.2. Market Analysis and Forecast by Market Taxonomy 18.8.2.2.1. By Product 18.8.2.2.2. By End User 18.8.3. South Africa Market 18.8.3.1. Introduction 18.8.3.2. Market Analysis and Forecast by Market Taxonomy 18.8.3.2.1. By Product 18.8.3.2.2. By End User 18.8.4. Northern Africa Market 18.8.4.1. Introduction 18.8.4.2. Market Analysis and Forecast by Market Taxonomy 18.8.4.2.1. By Product 18.8.4.2.2. By End User 19. Market Structure Analysis 19.1. Market Analysis by Tier of Companies 19.2. Market Share Analysis (%) of Top Players 19.3. Market Presence Analysis 19.3.1. Regional Footprint of Players 19.3.2. Product Footprint of Players 19.3.3. Channel Foot Print by Players 20. Competition Analysis 20.1. Competition Dashboard 20.2. Key Development Analysis 20.3. Promotional and Branding Strategies by Manufacturers 20.4. Competition Deep Dive 20.4.1. Medtronic plc 20.4.1.1. Overview 20.4.1.2. Product Portfolio 20.4.1.3. Sales Footprint 20.4.1.4. Key Financials 20.4.1.5. SWOT Analysis 20.4.1.6. Strategy Overview 20.4.1.6.1. Marketing Strategy 20.4.1.6.2. Product Strategy 20.4.1.6.3. Channel Strategy 20.4.2. Abbott Laboratories 20.4.2.1. Overview 20.4.2.2. Product Portfolio 20.4.2.3. Sales Footprint 20.4.2.4. Key Financials 20.4.2.5. SWOT Analysis 20.4.2.6. Strategy Overview 20.4.2.6.1. Marketing Strategy 20.4.2.6.2. Product Strategy 20.4.2.6.3. Channel Strategy 20.4.3. Boston Scientific Corporation 20.4.3.1. Overview 20.4.3.2. Product Portfolio 20.4.3.3. Sales Footprint 20.4.3.4. Key Financials 20.4.3.5. SWOT Analysis 20.4.3.6. Strategy Overview 20.4.3.6.1. Marketing Strategy 20.4.3.6.2. Product Strategy 20.4.3.6.3. Channel Strategy 20.4.4. Biotronik SE & Co. KG 20.4.4.1. Overview 20.4.4.2. Product Portfolio 20.4.4.3. Sales Footprint 20.4.4.4. Key Financials 20.4.4.5. SWOT Analysis 20.4.4.6. Strategy Overview 20.4.4.6.1. Marketing Strategy 20.4.4.6.2. Product Strategy 20.4.4.6.3. Channel Strategy 20.4.5. Schiller, Koninklijke Philips N.V. 20.4.5.1. Overview 20.4.5.2. Product Portfolio 20.4.5.3. Sales Footprint 20.4.5.4. Key Financials 20.4.5.5. SWOT Analysis 20.4.5.6. Strategy Overview 20.4.5.6.1. Marketing Strategy 20.4.5.6.2. Product Strategy 20.4.5.6.3. Channel Strategy 20.4.6. GE Healthcare and Wayra 20.4.6.1. Overview 20.4.6.2. Product Portfolio 20.4.6.3. Sales Footprint 20.4.6.4. Key Financials 20.4.6.5. SWOT Analysis 20.4.6.6. Strategy Overview 20.4.6.6.1. Marketing Strategy 20.4.6.6.2. Product Strategy 20.4.6.6.3. Channel Strategy 20.4.7. Siemens Healthcare 20.4.7.1. Overview 20.4.7.2. Product Portfolio 20.4.7.3. Sales Footprint 20.4.7.4. Key Financials 20.4.7.5. SWOT Analysis 20.4.7.6. Strategy Overview 20.4.7.6.1. Marketing Strategy 20.4.7.6.2. Product Strategy 20.4.7.6.3. Channel Strategy 20.4.8. Lepu Medical 20.4.8.1. Overview 20.4.8.2. Product Portfolio 20.4.8.3. Sales Footprint 20.4.8.4. Key Financials 20.4.8.5. SWOT Analysis 20.4.8.6. Strategy Overview 20.4.8.6.1. Marketing Strategy 20.4.8.6.2. Product Strategy 20.4.8.6.3. Channel Strategy 20.4.9. Midmark Corp 20.4.9.1. Overview 20.4.9.2. Product Portfolio 20.4.9.3. Sales Footprint 20.4.9.4. Key Financials 20.4.9.5. SWOT Analysis 20.4.9.6. Strategy Overview 20.4.9.6.1. Marketing Strategy 20.4.9.6.2. Product Strategy 20.4.9.6.3. Channel Strategy 20.4.10. Roche Ltd 20.4.10.1. Overview 20.4.10.2. Product Portfolio 20.4.10.3. Sales Footprint 20.4.10.4. Key Financials 20.4.10.5. SWOT Analysis 20.4.10.6. Strategy Overview 20.4.10.6.1. Marketing Strategy 20.4.10.6.2. Product Strategy 20.4.10.6.3. Channel Strategy 20.4.11. Randox Laboratories Ltd. 20.4.11.1. Overview 20.4.11.2. Product Portfolio 20.4.11.3. Sales Footprint 20.4.11.4. Key Financials 20.4.11.5. SWOT Analysis 20.4.11.6. Strategy Overview 20.4.11.6.1. Marketing Strategy 20.4.11.6.2. Product Strategy 20.4.11.6.3. Channel Strategy 20.4.12. Robonik India 20.4.12.1. Overview 20.4.12.2. Product Portfolio 20.4.12.3. Sales Footprint 20.4.12.4. Key Financials 20.4.12.5. SWOT Analysis 20.4.12.6. Strategy Overview 20.4.12.6.1. Marketing Strategy 20.4.12.6.2. Product Strategy 20.4.12.6.3. Channel Strategy 20.4.13. Diasorin 20.4.13.1. Overview 20.4.13.2. Product Portfolio 20.4.13.3. Sales Footprint 20.4.13.4. Key Financials 20.4.13.5. SWOT Analysis 20.4.13.6. Strategy Overview 20.4.13.6.1. Marketing Strategy 20.4.13.6.2. Product Strategy 20.4.13.6.3. Channel Strategy 20.4.14. Elabscience Biotechnology 20.4.14.1. Overview 20.4.14.2. Product Portfolio 20.4.14.3. Sales Footprint 20.4.14.4. Key Financials 20.4.14.5. SWOT Analysis 20.4.14.6. Strategy Overview 20.4.14.6.1. Marketing Strategy 20.4.14.6.2. Product Strategy 20.4.14.6.3. Channel Strategy 21. Assumptions and Acronyms Used 22. Research Methodology
Recommendations
Explore Healthcare Insights
View Reports